cardiomyopathy

Graphic of a fork in the road with arrows pointing in either direction

Biotech

BMS' MyoKardia scraps heart muscle pact with Fulcrum

MyoKardia, a biotech BMS bought in 2020, was working with Fulcrum to find cardiomyopathy targets but recently decided to end the alliance.

Nick Paul Taylor Mar 5, 2025 5:30am

heart monitor

BridgeBio touts extension study data for ATTR-CM drug acoramidis

Nov 18, 2024 3:38pm

heart cardiovascular check up stethescope

Intellia, Alnylam post data on contrasting cardiomyopathy ideas

Nov 18, 2024 7:40am

heart

Edgewise unveils promising early data for heart disease drug

Sep 20, 2024 4:00am

heart

BioMarin halts preclinical gene therapy for heart condition

Aug 6, 2024 9:01am

heart money

Bayer pays $310M for Europe rights to BridgeBio's Vyndaqel rival

Mar 4, 2024 8:22am